Rosetta Genomics Ltd.
64Patents
54Active
64Granted
51Portfolio score
Filing activity: Dec 6, 2002 → Nov 15, 2017 · 27 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7250496B2 | Bioinformatically detectable group of novel regulatory genes and uses thereof | Physics | 205 | Expired |
| US7655785B1 | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof | Chemistry; Metallurgy | 149 | Expired |
| US7618814B2 | Microrna-related nucleic acids and uses thereof | Physics | 84 | Expired |
| US7709616B2 | Micrornas and uses thereof | Emerging Cross-Sectional Technologies | 66 | Active |
| US7642348B2 | Prostate cancer-related nucleic acids | Chemistry; Metallurgy | 61 | Active |
| US7592441B2 | Liver cancer-related nucleic acids | Chemistry; Metallurgy | 60 | Active |
| US8207316B1 | HCMV-related nucleic acids and microRNA | Emerging Cross-Sectional Technologies | 51 | Active |
| US7687616B1 | Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof | Chemistry; Metallurgy | 45 | Active |
| US8084598B1 | Bioionformality detectable group of novel regulatory oligonucleotides and uses thereof | Physics | 41 | Active |
| US7217807B2 | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof | Emerging Cross-Sectional Technologies | 39 | Expired |
| US7825229B2 | Lung cancer-related nucleic acids | Chemistry; Metallurgy | 33 | Expired |
| US9708667B2 | MiRNA expression signature in the classification of thyroid tumors | Chemistry; Metallurgy | 33 | Active |
| US7888497B2 | Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof | Chemistry; Metallurgy | 31 | Active |
| US9096906B2 | Gene expression signature for classification of tissue of origin of tumor samples | Chemistry; Metallurgy | 26 | Active |
| US8163896B1 | Bioinformatically detectable group of novel regulatory genes and uses thereof | Chemistry; Metallurgy | 26 | Active |
| US7790867B2 | Vaccinia virus-related nucleic acids and microRNA | Emerging Cross-Sectional Technologies | 26 | Expired |
| US8802599B2 | Gene expression signature for classification of tissue of origin of tumor samples | Chemistry; Metallurgy | 25 | Active |
| US7696334B1 | Bioinformatically detectable human herpesvirus 5 regulatory gene | Chemistry; Metallurgy | 24 | Active |
| US7759478B1 | Bioinformatically detectable viral regulatory genes | Emerging Cross-Sectional Technologies | 23 | Expired |
| US8211867B2 | Targeting microRNAs for the treatment of liver cancer | Chemistry; Metallurgy | 22 | Active |
| US7943754B2 | Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof | Chemistry; Metallurgy | 22 | Active |
| US7777022B2 | Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof | Emerging Cross-Sectional Technologies | 19 | Active |
| US7795419B2 | Viral and viral associated miRNAs and uses thereof | Chemistry; Metallurgy | 19 | Active |
| US7696342B1 | Bioinformatically detectable group of novel viral regulatory genes and uses thereof | Chemistry; Metallurgy | 18 | Expired |
| US9115389B2 | Method for detecting a target nucleic acid comprising two portions using probes having a first portion complementary to the first portion of the target nucleic acid and a second portion substantially complementary to the second portion of the target nucleic acid | Chemistry; Metallurgy | 8 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.